Pfizer, BioNTech get vaccine 'fast track' from FDA

Video Credit: Reuters - Politics - Duration: 01:02s - Published 14 minutes ago

Pfizer, BioNTech get vaccine 'fast track' from FDA

Pfizer Inc and partner BioNTech SE said on Monday two of their experimental coronavirus vaccines received 'fast track' designation from the U.S. Food and Drug Administration, speeding up the regulatory review process.

Jillian Kitchener has more.

0 shares

Pfizer and its German partner BioNTech on Monday announced two of their experimental coronavirus vaccines received 'fast track' designation from the U.S. Food and Drug Administration.

...meaning the FDA may decide on an approval within six months.

If a vaccine candidate gets the green light, the companies said they expect to make up to 100 million doses by the end of this year.

The companies said the recent testing of an experimental vaccine on 24 healthy volunteers showed that after 28 days they had developed higher levels of COVID-19 antibodies than typically seen in infected people.

Upon regulatory approval, the companies expect to start a large trial with up to 30,000 participants… possibly later this month - paving the way toward a potential release of a vaccine.

The U.S. and other countries have poured billions into developing a safe and effective vaccine for COVID-19.

As of now - none are approved.

💡 newsR Knowledge: Other News Mentions

Pfizer American multinational pharmaceutical corporation

Sanofi eyes vaccine approval by early 2021 [Video]

Sanofi eyes vaccine approval by early 2021

French drugmaker Sanofi expects to get approval for the potential coronavirus vaccine it is developing with GlaxoSmithKline by the first half of next year. Francis Maguire reports.

Credit: Reuters Studio Duration: 01:13Published on January 1, 1970

Stocks rise on recovery hopes

U.S. stocks posted gains Monday as signs of U.S. economic recovery helped offset jitters over increasingly violent social unrest amid an ongoing pandemic and rising U.S.-China tensions. Fred Katayama reports.

Credit: Reuters Studio Duration: 01:22Published on January 1, 1970

AstraZeneca to make billion COVID vaccine doses if tests succeed [Video]

AstraZeneca to make billion COVID vaccine doses if tests succeed

AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on Thursday it should shortly get results of an early stage clinical trial. Ciara Lee reports

Credit: Reuters Studio Duration: 01:20Published on January 1, 1970

Food and Drug Administration Agency of the United States Department of Health and Human Services

Too soon to say if RNC will be safe -U.S. official [Video]

Too soon to say if RNC will be safe -U.S. official

Stephen Hahn, the Food and Drug Administration commissioner, said on Sunday it was "too early to tell" if it would be safe for people to attend August's Republican National Convention in Jacksonville, Florida. This report produced by Chris Dignam.

Credit: Reuters Studio Duration: 01:43Published on January 1, 1970

FDA Commissioner Won't Confirm Or Deny Trump's Unfounded COVID-19 Claim [Video]

FDA Commissioner Won't Confirm Or Deny Trump's Unfounded COVID-19 Claim

The commissioner of the US Food and Drug Administration on Sunday didn't defend a claim recently made by President Donald Trump. But according to CNN, he didn't support it, either. Dr. Stephen Hahn is a member of the White House coronavirus task force. At a White House Independence Day event on Saturday, Trump made an unfounded claim that 99% of coronavirus cases are 'totally harmless.' In a CNN interview with Dana Bash on Sunday, Dr.

Credit: Wochit News Duration: 00:45Published on January 1, 1970

Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment [Video]

Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment

Gilead is the pharmaceutical company behind a drug that’s been approved for COVID emergencies. The FDA officially announced the medicine could be used in treating COVID-19 patients. Gilead has now announced the drug will cost $3,120 per typical treatment course for insured individuals. Research has indicated the drug could cut the recovery time for hospitalized COVID-19 patients. It could shorten satsy by several days, reports Gizmodo.

Credit: Wochit News Duration: 00:35Published on January 1, 1970

Former FDA head says 'exponential' rise in COVID-19 possible [Video]

Former FDA head says 'exponential' rise in COVID-19 possible

Former Food and Drug Administration Commissioner Scott Gottlieb on Sunday warned that some U.S. states, including Texas, Florida and Arizona, could start to see an 'exponential' rise in COVID-19 cases this coming week. This report produced by Yahaira Jacquez.

Credit: Reuters - Politics Duration: 01:40Published on January 1, 1970

Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

COVID crisis may get "worse and worse": WHO [Video]

COVID crisis may get "worse and worse": WHO

The new coronavirus pandemic raging around the globe will worsen if countries fail to adhere to strict healthcare precautions, the World Health Organization has warned.

Credit: Reuters Studio Duration: 01:07Published on January 1, 1970

U.S. COVID-19 cases surge amid reopening debate [Video]

U.S. COVID-19 cases surge amid reopening debate

[NFA] Florida confirmed its place as an emerging epicenter of the COVID pandemic in the United States on Friday by reporting its second sharpest daily rise in cases while virus-related deaths across the country climb. Jillian Kitchener has more.

Credit: Reuters - Politics Duration: 02:05Published on January 1, 1970

U.S. COVID-19 cases surge amid reopenings debate [Video]

U.S. COVID-19 cases surge amid reopenings debate

[NFA] Florida confirmed its place as an emerging epicenter of the COVID pandemic in the United States on Friday by reporting its second sharpest daily rise in cases while virus-related deaths across the country climb. Jillian Kitchener has more.

Credit: Reuters - Politics Duration: 02:05Published on January 1, 1970

Trump bets re-opening schools may win votes [Video]

Trump bets re-opening schools may win votes

[NFA] The Republican president's re-election effort sees re-opening schools shuttered by the coronavirus as part of a plan to restore his standing among suburban voters. This report produced by Zachary Goelman.

Credit: Reuters - Politics Duration: 02:13Published on January 1, 1970

Tweets about this

Cam30 'Pfizer' & 'BioNTech''s Coronavirus Vaccine Candidates Get 'FDA''s 'fast track' Status: https://t.co/PhTNPy4oPp via @AOL 5 minutes ago

Pat Fuller #StopKillingBlackPeople #JustWearAMask RT @tinaissa: Pfizer gets fast track designation for their vaccine and the CEO says they can have a vaccine ready by this fall! Fantastic… 9 minutes ago

Harvest Portfolios Group Pfizer, BioNTech’s coronavirus vaccine candidates get FDA’s ‘fast track’ status. Looking at end of year.… https://t.co/3uc1gSL8vj 12 minutes ago

Alessandro Savelli New post in BuddySav's Trading Ideas - #Intra #Swing and #Mid-LongTerm View: NEWS BREAK CONFIRMED PFIZER AND BION… https://t.co/LhfViNVbNN 13 minutes ago

Market News🇱🇰 #US #stocks Dow surges over 450pts after Pfizer & BioNTech were granted fast track designation by FDA for 2 of the… https://t.co/O10m0BToJB 16 minutes ago

ᐺﾉり RT @SCMPNews: Pfizer, BioNTech’s shares rise after FDA grants ‘fast track’ status to two coronavirus vaccine candidates https://t.co/K0mQZY… 19 minutes ago

Devdiscourse Pfizer, BioNTech's coronavirus vaccine candidates get FDA's 'fast track' status https://t.co/K6aqex9vpZ 21 minutes ago

Ivonne JS RT @amtvmedia: Update: Positive news on the vaccine front lifted sentiment as well. Pfizer and German biotech BioNTech SE were granted fas… 22 minutes ago

Pfizer\, BioNTech get vaccine \'fast track\' from FDA